Seamless Histopathology services to accelerate your pipeline

NeoGenomics is a trusted leader in developing state-of-the-art histopathology testing solutions to empower our pharmaceutical partners. With over a decade of experience, we consistently provide high-quality, reliable results regardless of project scope or intended use, adhering to the most rigorous industry standards. 

 

 

hero anchor

Comprehensive Histopathology Capabilities

We offer end-to-end workflow from tissue processing, embedding, and microtomy to a wide range of downstream modalities designed to streamline your development timeline.

✓ 400+ validated biomarkers to support clinical trial needs✓ Advanced image analysis for qualitative and quantitative scoring
✓ Sub-specialized pathology expertise for precise evaluations and reporting✓ Extensive experience in prospecting tests needs and companion diagnostics (CDx) development
✓ Custom biomarker solutions for tailored development and validation of novel and emerging biomarkers 

Partner with us to accelerate biomarker detection, disease classification, patient cohort identification, prognosis assessment, therapeutic target validation, and tumor microenvironment characterization.

IHC/ISH services

High-throughput IHC and ISH Services

We provide flexible, high-throughput immunohistochemistry (IHC) and in situ hybridization (ISH) solutions across multiple IVD and RUO platforms such as Dako, Roche/Ventana Benchmark ULTRA, and Leica BOND-III/BOND RX to address your diverse program needs.

  • 300+ validated assays
  • 2,500+ stains per day
  • RNAscope™ assay development and validation
  • RUO, CTA, LDT, IVD, and CDx options
  • Virtual Hematoxylin and Eosin (H&E) staining for clear, comprehensive visualization of cellular structure

Whether you require batch processing or real-time turnaround, our services are optimized for accuracy, reproducibility, and sample adaptability. All services are performed under expert pathologist supervision to ensure the highest quality.

Spatial services

Unlock deep biological insights with advanced spatial technologies

 

Akoya PhenoImager 
Detect up to 6 protein biomarkers via multiplex immunofluorescence within a single tissue section.

Paletrra, exclusively through NeoGenomics 
Multiplex and hyperplex immunofluorescence detecting up to 60+ protein biomarkers with whole-tissue workflow, AI-powered image analysis at the single-cell level and advanced spatial analytics.

Bruker GeoMx Digital Spatial Profiler 
Combines standard immunofluorescence technology with digital optical barcoding technology to uncover morphologically guided, highly multiplexed, spatially resolved RNA and protein tissue profiling.

RareCyte® liquid biopsy 
A highly sensitive, unbiased, and reproducible workflow for circulating tumor cell (CTC) capture, enumeration, and single-cell isolation - enabling downstream analysis of cancer cell biomarker expression and mutational profiling.

Advance pathology and image analysis services

Expert Pathology and Image Analysis

Our board-certified pathologists provide specialized support across:

  • Surgical pathology
  • Hematopathology
  • Cytopathology
  • Molecular pathology

Pathology services include:

  • Pathologist-guided tumor scoring – slides or digital images
  • On-demand expert consultation

Image analysis tools:

  • India HALO® Brightfield
  • Indica HALO® Akoya PhenoImager
  • AI-driven image analysis and advanced spatial analytics via Paletrra
  • Digital imaging platform for accelerated decision making

Flexible, Technology-Agnostic Approach

We select the most suitable platforms for your program needs—ensuring unbiased, data-driven results.

 

Expertise You Can Trust. Resources You Can Act On.

   Explore our webinars, white papers, and other valuable resources

Get in touch

Explore how partnering with NeoGenomics Pharma Services can support you. ContactPharma@neogenomics.com